Patents by Inventor Mark Moran
Mark Moran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240104394Abstract: Provided are computing systems, methods, and platforms that automatically produce production-ready machine learning models and deployment pipelines from minimal input information such as a raw training dataset. In particular, one example computing system can import a training dataset associated with a user. The computing system can execute an origination machine learning pipeline to perform a model architecture search that selects and trains a machine learning model for the training dataset. Execution of the origination machine learning pipeline can also result in generation of a deployment machine learning pipeline configured to enable deployment of the machine learning model (e.g., running the machine learning model to produce inferences and/or optionally other tasks such as re-training and/or re-tuning the model).Type: ApplicationFiled: March 11, 2022Publication date: March 28, 2024Inventors: Amy Skerry-Ryan, Quentin Lascombes de Laroussilhe, Ronald Rong Yang, Carla Marie Riggi, Chansoo Lee, Jordan Arthur Grimstad, Christopher Mark Lamb, Joseph Michael Moran, Nihesh Anderson Klutto Milleth, Noah Weston Hadfield-Menell, Volodymyr Shtenovych, Ziqi Huang, Sagi Perel, Michael David Gerard, Mehadi Seid Hassen
-
Patent number: 11731749Abstract: A system for alleviating variations in torsional loads applied to a shaft coupled to a main engine of a marine vessel, said shaft is coupled to a propeller of the marine vessel, the system comprising an electric motor-generator configured to provide power to the shaft or take out power from the shaft; a controller coupled to the electric motor-generator said controller is configured to execute instructions, comprising: measuring a group of values that are indicative of torsional loads applied on a shaft of the marine vessel over time; creating a time-based series of values that represent a predictive time-based torsional loads on the marine vessel; collecting readings indicative of power provided by a main engine of the marine vessel; computing an intervention time series of power values to be outputted by the electric motor-generator; wherein the electrical power outputs the intervention time series values of power to the shaft.Type: GrantFiled: December 29, 2022Date of Patent: August 22, 2023Assignee: MARINE EDGE LTD.Inventors: Mark Moran, Nevo Dotan, Amichay Haim Gross
-
Publication number: 20210121756Abstract: A ball game apparatus including a centerpiece apparatus member having an outer frame member, an inner frame member, and a raised platform surface disposed within the inner frame member, a plurality of shaped members coupled between the outer and inner frame members, and a ball member configured to bounce off the raised platform surface and the plurality of shaped members.Type: ApplicationFiled: October 28, 2019Publication date: April 29, 2021Inventor: Mark Moran
-
Publication number: 20200383951Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.Type: ApplicationFiled: January 7, 2020Publication date: December 10, 2020Inventors: Tom Woiwode, Mark Moran, Lesley Pickford
-
Patent number: 10624905Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: GrantFiled: March 27, 2018Date of Patent: April 21, 2020Assignee: Flexion Therapeutics, Inc.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Publication number: 20200079164Abstract: A method operable in a towing vehicle for determining a state of a trailer being towed by said towing vehicle is disclosed. The vehicle comprises a front facing and a rear facing image capturing device and the method comprises determining respective distances of the rear facing image capturing device and the front facing image capturing device from a surface on which the vehicle lies. Responsive to one or both of: the distance of the rear image capturing device being outside a first threshold, and the distance of the front image capturing device being outside a second threshold, a value indicative the state of the towed trailer is output.Type: ApplicationFiled: September 10, 2019Publication date: March 12, 2020Applicant: Connaught Electronics Ltd.Inventors: Brian Finan, Mark Moran
-
Patent number: 10561638Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.Type: GrantFiled: December 6, 2013Date of Patent: February 18, 2020Assignee: Biotie Therapies, Inc.Inventors: Tom Woiwode, Mark Moran, Lesley Pickford
-
Publication number: 20180311260Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: March 27, 2018Publication date: November 1, 2018Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 9949987Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: GrantFiled: March 15, 2017Date of Patent: April 24, 2018Assignee: Flexion Therapeutics, Inc.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 9741134Abstract: A method to determine the volume of a box object from the captured image of the box object. The method includes identifying a geometric mark on the box object in the captured image to find the positions of two reference points of the geometric mark. The two reference points are separated by a predetermined distance. The method also includes processing a group of parameters and a predetermined mapping obtained from a calibration process. The group of parameters includes the positions of the two reference points and the predetermined distance separating the two reference points.Type: GrantFiled: December 16, 2013Date of Patent: August 22, 2017Assignee: Symbol Technologies, LLCInventors: Mark Moran, Menahem Diamantstein, Joel Nahum, Eyal Katz
-
Publication number: 20170182068Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: March 15, 2017Publication date: June 29, 2017Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Publication number: 20170135957Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: January 31, 2017Publication date: May 18, 2017Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 9555047Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: GrantFiled: August 18, 2014Date of Patent: January 31, 2017Assignee: FLEXION THERAPEUTICS, INC.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 9555048Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: GrantFiled: August 18, 2014Date of Patent: January 31, 2017Assignee: FLEXION THERAPEUTICS, INC.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Publication number: 20150170378Abstract: A method to determine the volume of a box object from the captured image of the box object. The method includes identifying a geometric mark on the box object in the captured image to find the positions of two reference points of the geometric mark. The two reference points are separated by a predetermined distance. The method also includes processing a group of parameters and a predetermined mapping obtained from a calibration process. The group of parameters includes the positions of the two reference points and the predetermined distance separating the two reference points.Type: ApplicationFiled: December 16, 2013Publication date: June 18, 2015Inventors: MARK MORAN, MENAHEM DIAMANTSTEIN, JOEL NAHUM, EYAL KATZ
-
Publication number: 20150025050Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: August 18, 2014Publication date: January 22, 2015Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Publication number: 20140356437Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: August 18, 2014Publication date: December 4, 2014Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 8828440Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: GrantFiled: March 16, 2012Date of Patent: September 9, 2014Assignee: Flexion Therapeutics, Inc.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Publication number: 20140242170Abstract: Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.Type: ApplicationFiled: December 16, 2013Publication date: August 28, 2014Applicant: FLEXION THERAPEUTICS, INC.Inventors: Neil Bodick, Robert C. Blanks, Anjali Kumar, Michael D. Clayman, Mark Moran
-
Patent number: 8811429Abstract: A storage router and related method are presented for combining multiple host frames, such as Fiber Channel frames, together into a single datagram for tunneling transmission over an IP or similar network. The storage router operates by storing incoming host frames in a host frame buffer. When there is sufficient data in the buffer, multiple host frames are batched together, compressed, and converted into an IP datagram. The number of host frames to be batched together can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the datagram arrives at the final destination, the segmented datagram is reconstructed, decompressed, and the multiple host frames are then extracted and passed on to the recipient host frame network.Type: GrantFiled: February 19, 2004Date of Patent: August 19, 2014Assignee: Brocade Communications Systems, Inc.Inventors: William C. Collette, Mark Moran, Robert Engebretson, Mike Morandi, Brian Johnson